Literature DB >> 15867843

Adipose tissue, adipokines, and inflammation.

Giamila Fantuzzi1.   

Abstract

White adipose tissue is no longer considered an inert tissue mainly devoted to energy storage but is emerging as an active participant in regulating physiologic and pathologic processes, including immunity and inflammation. Macrophages are components of adipose tissue and actively participate in its activities. Furthermore, cross-talk between lymphocytes and adipocytes can lead to immune regulation. Adipose tissue produces and releases a variety of proinflammatory and anti-inflammatory factors, including the adipokines leptin, adiponectin, resistin, and visfatin, as well as cytokines and chemokines, such as TNF-alpha, IL-6, monocyte chemoattractant protein 1, and others. Proinflammatory molecules produced by adipose tissue have been implicated as active participants in the development of insulin resistance and the increased risk of cardiovascular disease associated with obesity. In contrast, reduced leptin levels might predispose to increased susceptibility to infection caused by reduced T-cell responses in malnourished individuals. Altered adipokine levels have been observed in a variety of inflammatory conditions, although their pathogenic role has not been completely clarified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867843     DOI: 10.1016/j.jaci.2005.02.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  684 in total

Review 1.  Obesity in cancer survival.

Authors:  Niyati Parekh; Urmila Chandran; Elisa V Bandera
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

2.  Low serum adiponectin predicts future risk for asthma in women.

Authors:  Akshay Sood; Clifford Qualls; Mark Schuyler; Bharat Thyagarajan; Michael W Steffes; Lewis J Smith; David R Jacobs
Journal:  Am J Respir Crit Care Med       Date:  2012-04-06       Impact factor: 21.405

Review 3.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

4.  Changes of inflammatory mediators in obese patients after laparoscopic cholecystectomy.

Authors:  Gaetano Di Vita; Rosalia Patti; Fausto Famà; Carmela Rita Balistreri; Giuseppina Candore; Calogero Caruso
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 5.  Adipose tissue lymphocytes: types and roles.

Authors:  S Caspar-Bauguil; B Cousin; S Bour; L Casteilla; L Castiella; L Penicaud; C Carpéné
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

6.  Adipokines are associated with lower extremity venous disease: the San Diego population study.

Authors:  M A Allison; M Cushman; P W Callas; J O Denenberg; N E Jensky; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

7.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

8.  Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice.

Authors:  Maria Pini; Melissa E Gove; Raja Fayad; Robert J Cabay; Giamila Fantuzzi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-12       Impact factor: 4.052

9.  Obesity as a risk factor for severe acute pancreatitis patients.

Authors:  Jana Katuchova; Juraj Bober; Pavol Harbulak; Alexander Hudak; Tomas Gajdzik; Rastislav Kalanin; Jozef Radonak
Journal:  Wien Klin Wochenschr       Date:  2014-02-13       Impact factor: 1.704

10.  Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort.

Authors:  Y Morimoto; S M Conroy; N J Ollberding; Y Kim; U Lim; R V Cooney; A A Franke; L R Wilkens; B Y Hernandez; M T Goodman; B E Henderson; L N Kolonel; L Le Marchand; G Maskarinec
Journal:  Int J Obes (Lond)       Date:  2014-02-13       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.